Table 1.
2019 N = 216 pts. | 2020 N = 103 pts | p value | |
---|---|---|---|
Age, n, mean (SD) | 65.1 (18.8) | 65.4 (17.7) | 0.9 |
Female sex, n, % | 110 (50.9) | 40 (38.8) | 0.04* |
Arterial hypertension, n, % | 133 (61.6) | 62 (60.2) | 0.8 |
Diabetes, n, % | 35 (16.3) | 24 (23.3) | 0.13 |
Cardiopathy, n, % | 61 (28.2) | 32 (31.1) | 0.6 |
COPD, n, % | 16 (7.4) | 8 (7.8) | 0.9 |
History of cancer, n, % | 26 (12) | 15 (14.6) | 0.5 |
Obesity, n, % | 7 (3.2) | 7 (6.8) | 0.1 |
Neurodegenerative disease, n, % | 23 (10.6) | 16 (15.5) | 0.2 |
Chronic kidney failure, n, % | 9 (4.2) | 6 (5.8) | 0.5 |
Peripheral arterial disease, n, % | 12 (5.6) | 16 (15.5) | 0.003* |
History of previous stroke, n, % | 22 (10.2) | 12 (11.9) | 0.6 |
History of MS or autoimmune disease, n, % | 9 (4.2) | 6 (5.9) | 0.5 |
Number of comorbidities, n, mean (SD) | 1.6 (1.3) | 1.9 (1.5) | 0.06 |
Length of hospitalization, n (SD) | 14.2 (14.3) | 11.4 (8.4) | 0.2 |
Number of invasive devices, n, mean (SD) | 1.5 (0.7) | 1.7 (0.6) | 0.002* |
Central venous catheters, n, % | 20 (9.3) | 10 (9.7) | 0.9 |
Number of antibiotics, n, mean (SD) | 0.75 (1.5) | 0.63 (1.3) | 0.039* |
Subjects admitted for stroke, n, % | 114 (52.8) | 48 (46.6) | 0.3 |
Abbreviations: COPD = chronic obstructive pulmonary disease; MS = multiple sclerosis; SD = standard deviation. * p value less than 0.05.